Homepage
Medication Guide
Procurement Channels for Epalrestat
Epalrestat is an aldose reductase inhibitor that was first approved in Japan in 1992. It is mainly used for the treatment of diabetic peripheral neuropathy. Its mechanism of action involves inhibiting...
505
Friday, November 14th, 2025, 13:24
What Are the Precautions for Taking Dimemorfan Phosphate Tablets (Astomin)?
Dimemorfan Phosphate Tablets (Astomin) are a type of non-narcotic central antitussive. Since its first approval in Japan in 1975, it has been widely used to relieve cough symptoms in adults due to its...
503
Friday, November 14th, 2025, 13:19
What Are the Indications of Dimemorfan Phosphate Tablets (Astomin)?
Dimemorfan Phosphate Tablets (Astomin) are non-narcotic central antitussives. Owing to their low side effects and low addictiveness, they exhibit unique value in clinical practice.What Are the Indicat...
503
Friday, November 14th, 2025, 13:12
What Are the Side Effects of Enasidenib?
Enasidenib is a targeted medication for isocitrate dehydrogenase-2 (IDH2) mutations, indicated for adult patients with relapsed or refractory acute myeloid leukemia (AML). As a prescription-only drug,...
504
Friday, November 14th, 2025, 11:20
What are the Precautions for Taking Enasidenib?
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor that provides a targeted treatment option for patients with relapsed or refractory acute myeloid leukemia (AML).What are the Precautions fo...
501
Friday, November 14th, 2025, 10:37
Dosage and Administration of Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leuke...
502
Friday, November 14th, 2025, 10:34
Indications for Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor indicated for the treatment of relapsed or refractory acute myeloid leukemia (AML) with specific gene mutation types.Indications for Enasid...
502
Friday, November 14th, 2025, 10:31
Procurement Channels for Enasidenib
Enasidenib is a targeted medication for the treatment of relapsed or refractory acute myeloid leukemia (AML). Its rational use is of crucial importance to patients. Due to the specific nature of this ...
502
Friday, November 14th, 2025, 10:27
Precautions for Administration of Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia)
Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia) is a fixed-dose combination preparation of a DPP-4 inhibitor and an SGLT2 inhibitor developed by Mitsubishi Tanabe Pharma (Japan)...
503
Friday, November 14th, 2025, 10:14
Indications for Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia)
Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia) is a dual-mechanism antidiabetic fixed-dose combination preparation developed by Mitsubishi Tanabe Pharma (Japan) and co-promoted...
503
Friday, November 14th, 2025, 10:11
34 / 185
1842 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved